"I am quite fortunate to work in an environment where we can provide state-of-the-art medical care to our patients while at the same time participate in clinical research and education of our future healthcare providers."
Dr. William Owen
American Board of Pediatrics
Medical School: Bowman Gray School of Medicine
Residency: Children's National Medical Center
Fellowship: Children's National Medical Center
Dr. Owen graduated
from the University of North Carolina at Chapel Hill with a degree in zoology
and psychology, and he remains an avid Tar Heel fan. He has served as the
leader in the development of several clinical programs at CHKD, including
the peripheral stem cell transplantation and comprehensive sickle cell
programs. He has also served in various roles on regional, state
and national committees ranging from chairman of the EVMS admissions
committee to a participant on the sickle cell disease expert panel for
development of quality of care indicators at Boston University.
- Interventions to
prevent primary and secondary stroke in sickle cell disease
Novel drugs to decrease the complications associated with sickle cell disease
- Implementation of state-of-the-art medical therapies in underdeveloped
- General pediatric
- Sickle cell disease
- Immunological diseases which affect the blood and bone marrow
- Histiocytic diseases
Honors & awards
- Coastal Virginia Magazine "Top Doc" 2014
- Alpha Omega Alpha
Honor Medical Society
Named as one of the "Top Doctors in Hampton Roads"
Dr. Owen has a strong
interest in global health and has made multiple trips to Haiti and the
Dominican Republic to provide direct health care, to help establish medical
screening programs, and to aid in the educational process of local medical
Alvarez O, Yovetich
NA, Scott JP, Owen W, et.al. Pain and other non-neurological adverse events in
children with sickle cell anemia and previous stroke who received hydroxyurea
and phlebotomy or chronic transfusions and chelation: results from the SWiTCH
clinical trial. American Journal of Hematology. 2013 Nov:88(11):932-938.
McCarville M, Rogers Z, Sarnaik S, Scott P, Aygun B, Hilliard L, Lee M,
Kalinyak M, Owen W, et. al. Effects of Chronic Transfusions on Abdominal
Sonographic Abnormalities in Children with Sickle Cell Anemia. Journal of
Pediatrics. 2012 Feb;160(2):281-285.
Fung E, Harmatz P, Milet M, Ballas S, Decastro L, Hagar W, Hilliard L, Owen W,
et al. Morbidity and Mortality in Transfused Subjects with Thalassemia and
Sickle Cell Disease: A Report of the Multicenter Iron Overload Study. American
Journal of Hematology 2007 Apr;82(4):255-265.
Whitlock J, Krailo M, Reid J, Ruben S, Ames M, Owen W, and Reaman G. Phase I
Clinical and Pharmacokinetic Study of Flavopiridol in Children with Refractory
Solid Tumors: A Children's Oncology Group Study. Journal of Clinical Oncology